Discovery of Ketone-Based Covalent Inhibitors of Coronavirus 3CL Proteases for the Potential Therapeutic Treatment of COVID-19
Pfizer (United States) · Southern Research Institute
Indexed incrossrefdatacitepubmed
Abstract
With suitable pharmaceutical properties to warrant further development as an intravenous treatment for COVID-19.
Citation impact
530
total citations
- FWCI
- 9.65
- Percentile
- 100%
- References
- 45
Citations per year
Authors
24Topics & keywords
Topics
Keywords
- Coronavirus
- Chemistry
- Proteases
- Polyproteins
- Protease
- Cleavage (geology)
- Cysteine protease
- Virology
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.